gla-af
Small moleculeexperimental
Clinical trial activity
11 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01397604)
Timeline
Indications
Mechanism of action
- Unspecified target
immunity, active - adjuvant
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314986 ↗
Also known as
- gla-af
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03172975 | Phase 2 | Jul 15, 2017 | Baylor University, George Washington University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT03110757 | Phase 1 | Jun 29, 2017 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02476773 | Phase 1 | Jan 1, 2016 | Baylor University, George Washington University, Johns Hopkins University, University of California, San Francisco |
| NCT02337855 | Phase 1 | Feb 4, 2015 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01966900 | Phase 1 | Oct 1, 2013 | National Institute for Health Research, United Kingdom, University of London, Wellcome Trust |
| NCT01922284 | Phase 1 | Jun 1, 2013 | Medical Research Council, University of London, Wellcome Trust |
| NCT01864876 | Phase 1 | Sep 1, 2012 | Immune Design, Infectious Disease Research Institute, Rockefeller University |
| NCT01657929 | Phase 1 | Sep 1, 2012 | Defense Advanced Research Projects Agency, Immune Design, Infectious Disease Research Institute, Medicago |
| NCT01385189 | Phase 1 | May 1, 2012 | Albert B. Sabin Vaccine Institute, Children's National Medical Center, George Washington University |
| NCT01261130 | Phase 1 | Nov 1, 2011 | Albert B. Sabin Vaccine Institute, Baylor University |
| NCT01397604 | Phase 1 | Jul 1, 2011 | Immune Design, Rockefeller University |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 3 | 3 | 2 | 2011 |
| George Washington University | Academic/Hospital | 3 | 0 | 2 | 2012 |
| Immune Design | For profit | 3 | 0 | 1 | 2011 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 2 | 2 | 2015 |
| Albert B. Sabin Vaccine Institute | Academic/Hospital | 2 | 1 | 1 | 2011 |
| Infectious Disease Research Institute | Academic/Hospital | 2 | 2 | 1 | 2012 |
| Rockefeller University | Academic/Hospital | 2 | 1 | 1 | 2011 |
| University of London | Academic/Hospital | 2 | 2 | 1 | 2013 |
| Wellcome Trust | Academic/Hospital | 2 | 0 | 1 | 2013 |
| Children's National Medical Center | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Defense Advanced Research Projects Agency | Government | 1 | 0 | 1 | 2012 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Medicago | For profit | 1 | 0 | 1 | 2012 |
| Medical Research Council | Government | 1 | 0 | 1 | 2013 |
| National Institute for Health Research, United Kingdom | Government | 1 | 0 | 1 | 2013 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2016 |
16 organizations
Page 1 / 1